Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES)
Completed · Not applicable
Conditions studied: Venous Reflux
In brief
The VenaSeal Closure system offers an outpatient treatment option for the permanent closure of lower extremity superficial truncal veins, such as the great saphenous vein (GSV), through endovascular embolization with coaptation. VenaSeal is intended for use in adults with clinically symptomatic venous reflux as diagnosed by duplex ultrasound (DUS).
Key facts
- Study ID
- NCT02585726
- Run by
- Lake Washington Vascular
- People needed
- 50
- Starts
- 2015-10-01
- Expected to finish
- 2017-07-01
- Last updated by the study team
- 2018-03-16
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- Lake Washington Vascular, PLLC — Bellevue, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.